dihydroxyphenylalanine has been researched along with Biliary Tract Cancer in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buck, AK | 1 |
| Herrmann, K | 1 |
| Eckel, F | 1 |
| Beer, AJ | 1 |
1 other study available for dihydroxyphenylalanine and Biliary Tract Cancer
| Article | Year |
|---|---|
Pancreatic and hepatobiliary cancers.
Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; | 2011 |